| Behavior Education Language & Lifeskills, Inc. | |
|
3335 Carter Rd Mims FL 32754-5380 | |
| (321) 759-5462 | |
| (407) 960-3009 |
| Full Name | Behavior Education Language & Lifeskills, Inc. |
|---|---|
| Speciality | Behavior Analyst |
| Location | 3335 Carter Rd, Mims, Florida |
| Authorized Official Name and Position | Holly Bell (PRESIDENT) |
| Authorized Official Contact | 3217595462 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Behavior Education Language & Lifeskills, Inc. 3335 Carter Rd Mims FL 32754-5380 Ph: (321) 759-5462 | Behavior Education Language & Lifeskills, Inc. 3335 Carter Rd Mims FL 32754-5380 Ph: (321) 759-5462 |
| NPI Number | 1306511472 |
|---|---|
| Provider Enumeration Date | 08/11/2021 |
| Last Update Date | 08/11/2021 |
| Certification Date | 08/11/2021 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306511472 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103K00000X | Behavior Analyst | (* (Not Available)) | Primary |
News Archive
Regardless of an individual's dietary and lifestyle risk factors, living in a poorer or more socioeconomically deprived neighborhood may increase a person's risk for death, according to data presented at the American Association for Cancer Research Conference on Frontiers in Cancer Prevention Research, held Dec. 6-9, 2009.
NanoString Technologies, Inc., a provider of life science tools for translational research and molecular diagnostic products, today announced new results from a combined analysis of the Austrian Breast & Colorectal Cancer Study Group 8 (ABCSG-8) and Trans-Arimidex, Tamoxifen, Alone or in Combination (TransATAC) studies. These results, which evaluated samples from 2,137 patients, suggest that the PAM50-based Prosignaz Breast Cancer Prognostic Gene Signature Assay may help identify women with late distant recurrence after five years of endocrine treatment.
Genentech, a member of the Roche Group, today announced the company will present results from studies of its investigational medicine pertuzumab in HER2-positive breast cancer at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium December 6-10.
Federal, state, and local agencies have reached consensus on the first validated national standard for collecting, packaging, and transporting samples of visible powders that are suspected of being biological threat agents, such as anthrax.
Allergic rhinitis does not appear to be associated with snoring or daytime sleepiness, but individuals with obstructed nasal passages are likely to experience both regardless of whether they have allergies, according to a report in the December issue of Archives of Otolaryngology-Head & Neck Surgery.
› Verified 6 days ago